Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Net Income: 2020-2025

Historic Net Income for Tango Therapeutics (TNGX) over the last 6 years, with Sep 2025 value amounting to $15.9 million.

  • Tango Therapeutics' Net Income rose 154.46% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$100.5 million, marking a year-over-year increase of 18.57%. This contributed to the annual value of -$130.3 million for FY2024, which is 28.07% down from last year.
  • As of Q3 2025, Tango Therapeutics' Net Income stood at $15.9 million, which was up 140.88% from -$38.9 million recorded in Q2 2025.
  • In the past 5 years, Tango Therapeutics' Net Income registered a high of $15.9 million during Q3 2025, and its lowest value of -$39.9 million during Q1 2025.
  • For the 3-year period, Tango Therapeutics' Net Income averaged around -$26.8 million, with its median value being -$29.2 million (2024).
  • As far as peak fluctuations go, Tango Therapeutics' Net Income crashed by 951,806.78% in 2021, and later spiked by 154.46% in 2025.
  • Over the past 5 years, Tango Therapeutics' Net Income (Quarterly) stood at -$22.1 million in 2021, then slumped by 31.98% to -$29.1 million in 2022, then declined by 5.65% to -$30.8 million in 2023, then dropped by 22.37% to -$37.6 million in 2024, then soared by 154.46% to $15.9 million in 2025.
  • Its last three reported values are $15.9 million in Q3 2025, -$38.9 million for Q2 2025, and -$39.9 million during Q1 2025.